[Journal logo]

Volume 64 
Part 9 
Page o1844  
September 2008  

Received 20 August 2008
Accepted 24 August 2008
Online 30 August 2008

Key indicators
Single-crystal X-ray study
T = 298 K
Mean [sigma](C-C) = 0.005 Å
R = 0.052
wR = 0.152
Data-to-parameter ratio = 15.0
Details
Open access

9-(4-Fluorophenyl)-3,3,6,6-tetramethyl-10-p-tolyl-1,2,3,4,5,6,7,8,9,10-decahydroacridine-1,8-dione

aSchool of Chemistry and Chemical Engineering, Xuzhou Institute of Technology, Xuzhou 221006, People's Republic of China, and bSchool of Chemistry and Chemical Engineering, Xuzhou Normal University, Xuzhou 221116, People's Republic of China
Correspondence e-mail: laotu2001@263.net

The title compound, C30H32FNO2, was synthesized by the reaction of dimedone with 4-fluorobenzaldehyde and p-toluidine in water. The dihydropyridine and both of the cyclohexenone rings are not planar and have flattened boat conformations. The dihedral angle between the planar aromatic rings is 15.33 (3)°. In the crystal structure, intermolecular C-H...O hydrogen bonds link the molecules into centrosymmetric dimers.

Related literature

For general background, see: Wysocka-Skrzela & Ledochowski (1976[Wysocka-Skrzela, B. & Ledochowski, A. (1976). Rocz. Chem. 50, 127-131.]); Nasim & Brychcy (1979[Nasim, A. & Brychcy, T. (1979). Mutat. Res. 65, 261-288.]); Thull & Testa, (1994[Thull, U. & Testa, B. (1994). Biochem. Pharmacol. 47, 2307-2310.]); Reil et al. (1994[Reil, E., Scoll, M., Masson, K. & Oettmeier, W. (1994). Biochem. Soc. Trans. 22, s62.]); Mandi et al. (1994[Mandi, Y., Regely, K., Ocsovszky, I., Barbe, J., Galy, J. P. & Molnar, J. (1994). Anticancer Res. 14, 2633-2636.]). For related literature, see: Tu et al. (2004[Tu, S. J., Miao, C. B., Gao, Y., Fang, F., Zhuang, Q. Y., Feng, Y. J. & Shi, D. Q. (2004). Synlett, 2, 255-258.]). For ring puckering parameters, see: Cremer & Pople (1975[Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.]). For bond-length data, see: Allen et al. (1987[Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.]).

[Scheme 1]

Experimental

Crystal data
  • C30H32FNO2

  • Mr = 457.58

  • Monoclinic, P 21 /n

  • a = 15.1533 (15) Å

  • b = 10.9643 (12) Å

  • c = 16.1053 (15) Å

  • [beta] = 102.317 (2)°

  • V = 2614.2 (5) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 0.08 mm-1

  • T = 298 (2) K

  • 0.37 × 0.25 × 0.21 mm

Data collection
  • Bruker SMART CCD area-detector diffractometer

  • Absorption correction: multi-scan (SADABS; Sheldrick, 1996[Sheldrick, G. M. (1996). SADABS. University of Göttingen, Germany.]) Tmin = 0.972, Tmax = 0.984

  • 13238 measured reflections

  • 4605 independent reflections

  • 2277 reflections with I > 2[sigma](I)

  • Rint = 0.045

Refinement
  • R[F2 > 2[sigma](F2)] = 0.051

  • wR(F2) = 0.152

  • S = 1.02

  • 4605 reflections

  • 307 parameters

  • H-atom parameters constrained

  • [Delta][rho]max = 0.18 e Å-3

  • [Delta][rho]min = -0.20 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
C15-H15...O1i 0.93 2.45 3.336 (3) 159
Symmetry code: (i) -x+2, -y+1, -z.

Data collection: SMART (Bruker, 1997[Bruker (1997). SMART and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT (Bruker, 1997[Bruker (1997). SMART and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: SHELXTL (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); software used to prepare material for publication: SHELXTL.


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: HK2514 ).


Acknowledgements

We thank the Foundation of Xuzhou Institute of Technology (grant No. XKY2007241) for financial support.

References

Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.
Bruker (1997). SMART and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.  [CrossRef] [ChemPort] [ISI]
Mandi, Y., Regely, K., Ocsovszky, I., Barbe, J., Galy, J. P. & Molnar, J. (1994). Anticancer Res. 14, 2633-2636.  [ChemPort] [PubMed]
Nasim, A. & Brychcy, T. (1979). Mutat. Res. 65, 261-288.  [ChemPort] [PubMed]
Reil, E., Scoll, M., Masson, K. & Oettmeier, W. (1994). Biochem. Soc. Trans. 22, s62.
Sheldrick, G. M. (1996). SADABS. University of Göttingen, Germany.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Thull, U. & Testa, B. (1994). Biochem. Pharmacol. 47, 2307-2310.  [CrossRef] [ChemPort] [PubMed]
Tu, S. J., Miao, C. B., Gao, Y., Fang, F., Zhuang, Q. Y., Feng, Y. J. & Shi, D. Q. (2004). Synlett, 2, 255-258.  [CrossRef]
Wysocka-Skrzela, B. & Ledochowski, A. (1976). Rocz. Chem. 50, 127-131.  [ChemPort]


Acta Cryst (2008). E64, o1844  [ doi:10.1107/S1600536808027256 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.